Fig. 5
From: Global analysis of miRNA-mRNA regulation pair in bladder cancer
The ROC and DCA of the panel of miR-17-5p and TGFBR2 for discriminating BLCA patients from NCs. A: The ROC of the TCGA-BLCA (AUC = 0.929, 95% CI: 0.885-0.972, p < 0.0001); B: The ROC of the external validation (AUC = 0.767, 95% CI: 0.643–0.891, p = 0.001); C: The DCA of the TCGA-BLCA; D: The DCA of the external validation